Every 8-K that Canopy Growth Corporation (CGC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CGC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CGC filings page.
Canopy Growth Corporation reported a change in its external auditor. On August 7, 2026, PKF O’Connor Davies, LLP resigned as the independent registered public accounting firm due to strategic changes in its desire to provide services to the cannabis sector, and the audit committee accepted the resignation the same day.
The company states there were no disagreements with PKFOD on accounting principles, financial disclosures, or audit scope, and prior audit reports contained no adverse or disclaimed opinions. Those reports included an explanatory paragraph describing recurring losses and the need for additional capital that raised substantial doubt about Canopy Growth’s ability to continue as a going concern, which management concluded was alleviated by its plans. The company also discloses a material weakness in internal control related to review and approval of the classification of equity-linked instruments. The audit committee engaged MNP LLP as the new independent registered public accounting firm for the fiscal year ending March 31, 2027, and indicates there were no prior consultations with MNP on accounting or audit matters.
Canopy Growth Corporation reported improved Q1 FY2027 results for the three months ended June 30, 2026. Net revenue was $81,165 thousand, up 13% year-over-year, driven by cannabis net revenue of $65,085 thousand and Storz & Bickel revenue of $16,080 thousand. Canada medical cannabis grew 22% to $25,786 thousand, Canada adult-use rose 10% to $29,702 thousand, and international cannabis increased 10% to $9,597 thousand.
Consolidated gross margin improved to 27%, with adjusted gross margin at 31%. Net loss narrowed to $14,579 thousand, 68% lower than a year earlier, and adjusted EBITDA loss improved to $3,244 thousand from $7,916 thousand. Free cash flow was a negative $25,748 thousand as higher working capital needs increased cash used in operations. Management highlighted synergies from the MTL Cannabis acquisition, stronger Storz & Bickel margins, and a refreshed corporate identity aligned with its cannabis-focused growth strategy.
Canopy Growth Corporation reported fourth-quarter and full-year 2026 results showing modest revenue growth but ongoing losses. Net revenue reached about C$71.2 million in Q4 FY2026, up 10% from a year earlier, and C$284.6 million for FY2026, a 6% annual increase driven by 20% growth in Canadian adult-use cannabis and 18% growth in Canadian medical cannabis. International medical cannabis revenue grew 68% in Q4 but declined 7% for the year, while Storz & Bickel device revenue fell 14% both in the quarter and full year.
Reported gross margin compressed to 12% in Q4 and 24% for FY2026, though adjusted gross margin improved to 27% in Q4 after excluding acquisition-related inventory charges. The company posted a FY2026 net loss from continuing operations of C$262.9 million, about 49% narrower than FY2025, and an adjusted EBITDA loss of C$20.2 million. Free cash outflow improved significantly to C$69.1 million from C$176.6 million, and Canopy ended FY2026 with C$364.7 million in cash and a net cash position of C$131 million following a recapitalization. Management expects net revenue growth, better margins, lower operating costs and positive adjusted EBITDA in FY2027.
Canopy Growth Corporation has adopted a new Advance Notice By-Law, labeled By-Law No. 2, which was approved by its Board of Directors on May 26, 2026. This bylaw sets a formal process for shareholders to nominate directors at annual or special meetings.
The bylaw, which is already effective, must be submitted to shareholders for confirmation at the next annual general meeting expected in September 2026. It imposes clear deadlines, ownership thresholds and detailed disclosure requirements for any nominating shareholder, while allowing the Board to waive requirements at its discretion.
Canopy Growth Corporation is restating multiple past financial statements after identifying a non-cash technical accounting error related to certain U.S. dollar–denominated share-settled warrants. Because these warrants should have been treated as liabilities rather than equity, prior audited annual financials for fiscal years ended March 31, 2024 and 2025, and several interim quarterly results, should no longer be relied upon, and the related audit reports are also affected.
The company plans to correct this by filing a comprehensive Form 10-K for the year ended March 31, 2026, including restated figures, on June 15, 2026. Management expects the impact to be limited to balance sheet reclassifications and fair value adjustments that are non-cash and non-operational, with no change to underlying business performance. However, management expects to report a material weakness in internal control over financial reporting and has applied for a management cease trade order affecting certain directors and officers until the refiling is complete.
Canopy Growth Corporation completed its acquisition of MTL Cannabis, creating what it describes as Canada’s leading medical cannabis business by revenue. Under the arrangement, MTL shareholders received 0.32 Canopy Growth common share and $0.144 in cash per MTL share, for a total of approximately 41.2 million Canopy Growth shares and $18.5 million in cash, all in Canadian dollars.
Canopy Growth also issued 2,956,391 shares to certain former shareholders of Montreal Cannabis Medical in exchange for releasing prior obligations, with these shares subject to an 18‑month transfer restriction. The company highlights expected run‑rate synergies of about $10 million within 18 months and reiterates that integrating MTL’s profitable, cash‑generating operations supports its goal of achieving positive adjusted EBITDA during fiscal 2027. Several MTL leaders have joined Canopy Growth’s senior management, and MTL is now a wholly owned subsidiary whose shares are anticipated to be delisted from the CSE around March 16, 2026.
Canopy Growth reported Q3 FY2026 results showing stable revenue but much smaller losses and a stronger balance sheet. Net revenue was $74.5M, essentially flat year-over-year, with cannabis net revenue up 4% to $51.6M and Storz & Bickel revenue down 9% to $22.9M.
Consolidated gross margin was 29%, down from 32%, reflecting lower margins in both cannabis and Storz & Bickel. The net loss narrowed by about half to $62.6M, while Adjusted EBITDA loss improved to $(2.9)M. Free cash outflow improved to $(19.0)M from $(28.2)M.
Cash and cash equivalents rose to $371M, giving a net cash position of $146M as of December 31, 2025. Management highlights cost reductions, ongoing annualized savings of $29M, an on-track acquisition of MTL Cannabis, and a January 2026 recapitalization that pushed all debt maturities out to 2031.
Canopy Growth Corporation entered into a new senior secured loan and completed a major debt exchange and warrant issuance. The company received US$150,000,000 of cash proceeds under a senior secured loan with aggregate principal of US$162,115,000, funded with an original issue discount of US$12,115,000. The loan bears interest at Term SOFR (floor 3.25%) plus 6.25%, matures as late as January 31, 2031, and is secured by substantially all assets of the company and its material subsidiaries. Canopy plans to use the net proceeds to repay approximately US$101 million of existing senior secured debt, and for working capital, general corporate purposes, and potential future acquisitions.
In connection with this financing, the company issued 18,705,577 common share purchase warrants exercisable at US$1.30 per share for five years. Separately, Canopy exchanged C$96,358,375 of existing senior unsecured convertible debentures maturing in May 2029 for new convertible debentures with principal of C$55,000,000 maturing on July 8, 2031, plus 12,731,481 warrants at C$2.16 per share, 9,493,670 common shares, and a C$10,500,000 cash payment. The new debentures bear 7.50% annual interest and are convertible at C$1.83 per share, with a forced conversion feature if the Toronto Stock Exchange average closing price exceeds C$2.75 for 10 consecutive trading days. The company also amended its arrangement agreement with MTL Cannabis Corp. to refine how in-the-money MTL warrants are treated, requiring a cashless exercise notice to receive shares; otherwise, warrants are exchanged for replacement warrants on Canopy common shares.
Canopy Growth Corporation has agreed to acquire MTL Cannabis Corp. in a share-and-cash transaction. Each MTL share will receive 0.32 Canopy Growth share plus C$0.144 in cash, for a total of approximately 38 million Canopy Growth shares and C$17 million in cash based on MTL’s current non-diluted share count. Canopy Growth may issue up to an additional 2,956,391 shares to certain former MTL-related shareholders in exchange for releasing anti-dilution rights.
The acquisition will occur through a court-approved plan of arrangement and requires approvals from the Supreme Court of British Columbia, competition authorities and MTL shareholders, including a two-thirds vote and a separate minority approval. Holders of about 75% of MTL shares have signed support agreements, and roughly 72% of the Canopy shares issued for MTL will be subject to staggered lock-ups over three to twelve months. Closing is expected by the end of February 2026, subject to conditions and termination rights, including a C$4 million termination fee payable by MTL in certain competing-bid scenarios.
Canopy Growth Corporation furnished an update on its business by announcing fiscal second-quarter results for the period ended September 30, 2025. The company reported these results via a press release.
The press release was attached as Exhibit 99.1 and furnished under Item 2.02 (Results of Operations and Financial Condition). The company noted this information is furnished, not filed, under the Exchange Act.
Canopy Growth Corporation reported the final voting results from its 2025 Annual General and Special Meeting. Shareholders approved a share consolidation authorization, allowing the Board to set a consolidation ratio between 1-for-5 and 1-for-15 for common and exchangeable shares at any time prior to September 26, 2026. A total of 79,971,625 shares were represented out of 239,849,225 entitled to vote.
All five director nominees were elected. Shareholders approved the appointment of PKF O’Connor Davies, LLP as auditor for the fiscal year ending March 31, 2026. The advisory vote on executive compensation also passed.
Key tallies: the share consolidation resolution received 62,742,664 votes for, 16,557,315 against, and 671,647 abstentions; the auditor appointment received 75,518,055 votes for and 4,453,570 withheld.
Canopy Growth Corp filed an Form 8-K reporting an employment agreement effective September 17, 2025 between Canopy Growth USA, LLC and Thomas Stewart. The filing references standard 8-K items including departures/elections or appointments of officers or directors, Regulation FD disclosure, and financial statements and exhibits. The exhibits listed include the Employment Agreement, a Press Release dated September 17, 2025, and an embedded Inline XBRL cover page data file. The document is signed by Christelle Gedeon, Chief Legal Officer.
Canopy Growth Corporation filed an Form 8-K reporting Regulation FD disclosure and other events. The filing lists an Equity Distribution Agreement dated August 29, 2025 with BMO Capital Markets Corp. and BMO Nesbitt Burns Inc., legal opinion and consent from Cassels Brock & Blackwell LLP, and a press release dated August 29, 2025. The company also references an Interactive Data File (Inline XBRL) and notes that one non-material exhibit was omitted under Item 601(a)(5) of Regulation S-K, with supplemental copies available on request to the SEC.
The document is primarily an exhibits and disclosure notice; it does not include financial tables, earnings figures, or details of the equity distribution terms within the text provided here.
Canopy Growth Corporation filed a Form 8-K dated 8 Aug 2025. Under Item 2.02, the company furnished (not filed) a press release detailing fiscal Q1 FY26 results for the quarter ended 30 Jun 2025; the actual financial figures are contained in Exhibit 99.1 and are not included in this filing.
Under Item 5.02, the board appointed Margaret Shan Atkins as an independent director, effective 6 Aug 2025, and named her to the audit committee. The filing states there are no related-party transactions, and Ms. Atkins will receive standard director compensation and a customary indemnification agreement. No other material events, transactions or guidance updates are disclosed.